title: Ponatinib given for advanced leukemia relapse after allo-SCT.
authors.affiliation: Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Hirschbuehl
authors.affiliation: Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Rank
authors.affiliation: Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Pfeiffer
authors.affiliation: Onkologische Schwerpunktpraxis Augsburg, Augsburg, Germany.
authors.forename: H R
authors.initials: HR
authors.lastname: Slawik
authors.affiliation: Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Schlimok
authors.affiliation: Department of Hematology and Oncology, Klinikum Rechts der Isar, University of Munich, Munich, Germany.
authors.forename: H J
authors.initials: HJ
authors.lastname: Kolb
authors.affiliation: Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany.
authors.forename: Ch
authors.initials: Ch
authors.lastname: Schmid
mesh_terms: D000328:Adult; D064591:Allografts; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D011724:Pyridazines / Q000008:administration & dosage*; D012008:Recurrence; D033581:Stem Cell Transplantation
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D011724:Pyridazines; C545373:ponatinib